WESTBROOK, Maine, April 14, 2020 /PRNewswire/ — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 first quarter financial results for Thursday, April 30, 2020 before the market opens. The Company will host a conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.
The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-877-336-4441 or 1-409-207-6985 and reference access code 1103408.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.
Contact: John Ravis, Investor Relations, 1-207-556-8155
View original content to download multimedia:http://www.prnewswire.com/news-releases/idexx-laboratories-to-release-2020-first-quarter-financial-results-301040250.html
SOURCE IDEXX Laboratories, Inc.
BALTIMORE, Feb. 5, 2026 /PRNewswire/ -- RPI Consultants, a leading ERP implementation, optimization, and software firm…
LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for…
Patient catchment now includes 187 million+ patient lives, enables advanced analytics and AI modeling for…
The electron microscopy market is driven by rapid advancements in nanotechnology, increase in demand for…
VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / BioNxt Solutions Inc. ("BioNxt" or…
In the study, [68Ga]Ga-Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity…